Scribd Logo
Upload

Welcome to Scribd!

  • 8 views

    nrc1970 pt1

    Uploaded by

    Felipe Scholz Ramos
    Cutaneous side effects are common with EGFR inhibitors such as cetuximab and panitumumab. The most frequent adverse events are papulopustular eruptions and fissures occurring in 80-90% of patients. Management of these side effects aims to improve symptoms, allow continued treatment, and maintain the patient's quality of life with supportive care including topical antibiotics and retinoids.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    nrc1970 pt1

    Uploaded by

    Felipe Scholz Ramos
    8 views1 page
    Cutaneous side effects are common with EGFR inhibitors such as cetuximab and panitumumab. The most frequent adverse events are papulopustular eruptions and fissures occurring in 80-90% of patients. Management of these side effects aims to improve symptoms, allow continued treatment, and maintain the patient's quality of life with supportive care including topical antibiotics and retinoids.

    Original Description:

    Original Title

    nrc1970-pt1

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PPT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Cutaneous side effects are common with EGFR inhibitors such as cetuximab and panitumumab. The most frequent adverse events are papulopustular eruptions and fissures occurring in 80-90% of patients. Management of these side effects aims to improve symptoms, allow continued treatment, and maintain the patient's quality of life with supportive care including topical antibiotics and retinoids.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as ppt, pdf, or txt
    8 views1 page

    nrc1970 pt1

    Uploaded by

    Felipe Scholz Ramos
    Cutaneous side effects are common with EGFR inhibitors such as cetuximab and panitumumab. The most frequent adverse events are papulopustular eruptions and fissures occurring in 80-90% of patients. Management of these side effects aims to improve symptoms, allow continued treatment, and maintain the patient's quality of life with supportive care including topical antibiotics and retinoids.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as ppt, pdf, or txt
    of 1

    Lacouture Nature Reviews Cancer 6, 803812 (October 2006) | doi:10.

    1038/nrc1970

    You might also like